Effect of UGT polymorphisms on pharmacokinetics and adverse reactions of mycophenolic acid in kidney transplant patients
| Autor: | Zhenwei Jiang, Nan Hu |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
chemistry.chemical_classification business.industry medicine.medical_treatment Metabolism medicine.disease Mycophenolic acid UGT2B7 Immunosuppressive drug Therapeutic index Enzyme Pharmacokinetics chemistry Genetics medicine Molecular Medicine business Kidney transplantation medicine.drug |
| Zdroj: | Pharmacogenomics. 22:1019-1040 |
| ISSN: | 1744-8042 1462-2416 |
| DOI: | 10.2217/pgs-2021-0087 |
| Popis: | Mycophenolic acid (MPA) is a common immunosuppressive drug for kidney transplantation patients, and is characterized by a narrow therapeutic index and significant individual variability. UGTs are the main enzymes responsible for the metabolism of MPA. Although, many studies have focused on the relationship between UGT polymorphisms and pharmacokinetics and adverse reactions of MPA, the conclusion are controversial. We reviewed the relevant literature and summarized the significant influences of UGT polymorphisms, such as UGT1A8 (rs1042597, rs17863762), UGT1A9 (rs72551330, rs6714486, rs17868320, rs2741045, rs2741045) and UGT2B7 (rs7438135, rs7439366, rs7662029), on the pharmacokinetics of MPA and its metabolites and adverse reactions. The review provides a reference for guiding the individualized administration of MPA and reducing adverse reactions to MPA. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|